IP Library › Granted Patent US 7,494,976
Granted Patent B2
US 7,494,976 · App. 10/358,365 · Granted Feb 24, 2009

Caveolin peptides and their use as therapeutics

Assignee: Yale University
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,494,976
App. No.
10/358,365
Granted
Feb 24, 2009
Kind
B2
Abstract

The present invention relates generally to compositions and methods useful for treating various conditions and afflictions, such as inflammation and cancer. More specifically, the present invention relates to compositions and methods of treatment which utilize peptides comprising at least one caveolin scaffolding domain. Even more specifically, the present invention relates to compositions of fusion peptides comprising the antennapedia homeodomain fused to a caveolin scaffolding domain and to methods of using these peptides to treat various conditions and afflictions.

Claims (4)

1. An isolated peptide comprising the amino acid sequence of SEQ ID NO: 11.

2. A composition comprising the peptide of claim 1 .

3. The composition of claim 2 further comprising a carrier.

4. An isolated peptide consisting of the amino acid sequence of SEQ ID NO: 11.

Assignments (2)
SECURITY INTEREST Recorded Jul 5, 2016
From: CAVTHERX, INC.
To: CONNECTICUT INNOVATIONS, INCORPORATED
Reel/Frame 039071/0748 →
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded Apr 18, 2008
From: YALE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020826/0722 →
Continuity (3)
Division 0973102300 · Dec 7, 2000
Provisional Application 6023132700 · Sep 8, 2000
Related Publication 20030165510A1 · Sep 4, 2003